Showing 1 - 3 of 3 results
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Ipatasertib, an investigational Akt inhibitor, is currently in clinical development based on its potential to specifically target Akt in tumors with activated Akt signaling. Preclinical data have shown that ipatasertib selectively decreased cell viab...
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Ipatasertib, an investigational Akt inhibitor, is currently in clinical development based on its potential to specifically target Akt in tumors with activated Akt signaling. Preclinical data have shown that ipatasertib selectively decreased cell viab...
Class (Stereo):
CHEMICAL (ABSOLUTE)
Targets:
Ipatasertib, an investigational Akt inhibitor, is currently in clinical development based on its potential to specifically target Akt in tumors with activated Akt signaling. Preclinical data have shown that ipatasertib selectively decreased cell viab...